IGM Biosciences (IGMS) Presents At American Society of Hematology Meeting - Slideshow

Pioneering the Development of Engineered IgM Antibodies ASH 2020 Investor Conference Call December 5, 2020 Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that reflect the current views of IGM Biosciences, Inc. (the "Company," "we" or "our") with respect to the Company's future financial condition, results of operations, business strategy, expectations, milestones and plans. All statements other tha ...